AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 30.2 |
Market Cap | 13.36B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 2.54 |
PE Ratio (ttm) | 11.84 |
Forward PE | n/a |
Analyst | Buy |
Ask | 30.75 |
Volume | 5,024,206 |
Avg. Volume (20D) | 3,017,040 |
Open | 29.86 |
Previous Close | 29.99 |
Day's Range | 29.67 - 30.20 |
52-Week Range | 24.05 - 31.66 |
Beta | undefined |
About RPRX
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pha...
Analyst Forecast
According to 6 analyst ratings, the average rating for RPRX stock is "Buy." The 12-month stock price forecast is $41, which is an increase of 36.37% from the latest price.
Next Earnings Release
Analysts project revenue of $688.68M, reflecting a 15.55% YoY growth and earnings per share of 1.07, making a -6.96% decrease YoY.
2 months ago · seekingalpha.com
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +The 'Undercovered' Dozen series highlights 12 lesser-covered stocks from the past week, aiming to spark ideas and discussions among retail investors. Veradigm Inc. is undervalued due to regulatory pre...